| Dataset | Score | p-value 1 | p-value 2 | p-value 3 | 
|---|---|---|---|---|
| wolf-screen-ratio-mammosphere-adherent | 0.940 | 1.07e-15 | 2.23e-03 | 3.72e-02 | 

| Gene Symbol | Entrez Gene ID | Frequency | wolf-screen-ratio-mammosphere-adherent gene score | Best subnetwork score | Degree | wolf adherent-list Hits GI | wolf mammosphere no adherent-list Hits GI | 
|---|---|---|---|---|---|---|---|
| [ HIP1 ] | 3092 | 1 | 0.340 | 0.940 | 32 | - | - | 
| ACTB | 60 | 167 | 1.153 | 1.151 | 587 | Yes | - | 
| RSL24D1 | 51187 | 36 | 1.300 | 1.020 | 59 | Yes | - | 
| ACO2 | 50 | 50 | 1.000 | 1.076 | 191 | Yes | - | 
| EIF6 | 3692 | 14 | 0.700 | 1.013 | 267 | Yes | - | 
| EIF2S2 | 8894 | 27 | 1.075 | 1.138 | 81 | Yes | - | 
| CASP8 | 841 | 8 | 0.804 | 1.041 | 141 | - | - | 
| CLTC | 1213 | 35 | 0.884 | 1.138 | 247 | Yes | - | 
| PGD | 5226 | 75 | 1.201 | 1.106 | 138 | Yes | - | 
| Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources | 
|---|---|---|---|---|---|---|
| CLTC | 1213 | HIP1 | 3092 | pp | -- | int.I2D: BioGrid, BIND, HPRD, MINT; int.Mint: MI:0915(physical association); int.HPRD: in vitro, in vivo, yeast 2-hybrid | 
| EIF6 | 3692 | PGD | 5226 | pp | -- | int.I2D: YeastLow | 
| HIP1 | 3092 | EIF6 | 3692 | pp | -- | int.I2D: HPRD, BioGrid, StelzlHigh; int.HPRD: yeast 2-hybrid | 
| ACO2 | 50 | PGD | 5226 | pp | -- | int.I2D: YeastLow | 
| EIF6 | 3692 | RSL24D1 | 51187 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow | 
| ACTB | 60 | CLTC | 1213 | pp | -- | int.I2D: IntAct_Yeast | 
| CLTC | 1213 | EIF2S2 | 8894 | pp | -- | int.I2D: YeastLow | 
| ACO2 | 50 | EIF6 | 3692 | pp | -- | int.I2D: YeastLow | 
| CASP8 | 841 | HIP1 | 3092 | pp | -- | int.I2D: BioGrid, HPRD; int.HPRD: in vivo | 
| Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes | 
|---|---|---|---|---|---|---|---|
| GO:0030136 | clathrin-coated vesicle | 2.94e-04 | 1.00e+00 | 6.254 | 2 | 4 | 42 | 
| GO:0003743 | translation initiation factor activity | 4.01e-04 | 1.00e+00 | 6.031 | 2 | 8 | 49 | 
| GO:0005856 | cytoskeleton | 6.24e-04 | 1.00e+00 | 4.046 | 3 | 12 | 291 | 
| GO:0030690 | Noc1p-Noc2p complex | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 | 
| GO:0070243 | regulation of thymocyte apoptotic process | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 | 
| GO:0000054 | ribosomal subunit export from nucleus | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 | 
| GO:0019521 | D-gluconate metabolic process | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 | 
| GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 9.89e-04 | 1.00e+00 | 5.379 | 2 | 7 | 77 | 
| GO:0051538 | 3 iron, 4 sulfur cluster binding | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 | 
| GO:0002176 | male germ cell proliferation | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 | 
| GO:0019322 | pentose biosynthetic process | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 2 | 2 | 
| GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 | 
| GO:0003994 | aconitate hydratase activity | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 | 
| GO:0005200 | structural constituent of cytoskeleton | 1.38e-03 | 1.00e+00 | 5.138 | 2 | 8 | 91 | 
| GO:0005850 | eukaryotic translation initiation factor 2 complex | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 1 | 3 | 
| GO:1900126 | negative regulation of hyaluronan biosynthetic process | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 2 | 3 | 
| GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 1 | 3 | 
| GO:0036462 | TRAIL-activated apoptotic signaling pathway | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 1 | 3 | 
| GO:0009051 | pentose-phosphate shunt, oxidative branch | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 2 | 3 | 
| GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 1 | 3 | 
| GO:0071439 | clathrin complex | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 2 | 3 | 
| GO:0097190 | apoptotic signaling pathway | 2.11e-03 | 1.00e+00 | 4.826 | 2 | 6 | 113 | 
| GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 4 | 
| GO:0035877 | death effector domain binding | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 4 | 
| GO:0032051 | clathrin light chain binding | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 4 | 
| GO:1903077 | negative regulation of protein localization to plasma membrane | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 4 | 
| GO:0006413 | translational initiation | 2.83e-03 | 1.00e+00 | 4.613 | 2 | 17 | 131 | 
| GO:0042256 | mature ribosome assembly | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 | 
| GO:0006102 | isocitrate metabolic process | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 | 
| GO:0005638 | lamin filament | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 | 
| GO:0043023 | ribosomal large subunit binding | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 | 
| GO:0032025 | response to cobalt ion | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 | 
| GO:0061024 | membrane organization | 3.45e-03 | 1.00e+00 | 4.466 | 2 | 7 | 145 | 
| GO:0031265 | CD95 death-inducing signaling complex | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 6 | 
| GO:0030130 | clathrin coat of trans-Golgi network vesicle | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 3 | 6 | 
| GO:0030957 | Tat protein binding | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 3 | 6 | 
| GO:0031264 | death-inducing signaling complex | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 6 | 
| GO:0006101 | citrate metabolic process | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 6 | 
| GO:0030118 | clathrin coat | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 2 | 6 | 
| GO:0060546 | negative regulation of necroptotic process | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 1 | 7 | 
| GO:0030132 | clathrin coat of coated pit | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 2 | 7 | 
| GO:0097342 | ripoptosome | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 1 | 7 | 
| GO:0097202 | activation of cysteine-type endopeptidase activity | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 8 | 
| GO:0070688 | MLL5-L complex | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 8 | 
| GO:0097284 | hepatocyte apoptotic process | 5.60e-03 | 1.00e+00 | 7.476 | 1 | 3 | 9 | 
| GO:0006098 | pentose-phosphate shunt | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 4 | 10 | 
| GO:0001841 | neural tube formation | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 1 | 10 | 
| GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 11 | 
| GO:0045651 | positive regulation of macrophage differentiation | 6.85e-03 | 1.00e+00 | 7.187 | 1 | 1 | 11 | 
| GO:0042273 | ribosomal large subunit biogenesis | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 4 | 13 | 
| GO:0048268 | clathrin coat assembly | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 1 | 13 | 
| GO:0048260 | positive regulation of receptor-mediated endocytosis | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 2 | 13 | 
| GO:0030665 | clathrin-coated vesicle membrane | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 2 | 13 | 
| GO:0035267 | NuA4 histone acetyltransferase complex | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 4 | 14 | 
| GO:0030225 | macrophage differentiation | 9.32e-03 | 1.00e+00 | 6.739 | 1 | 1 | 15 | 
| GO:0005123 | death receptor binding | 9.32e-03 | 1.00e+00 | 6.739 | 1 | 1 | 15 | 
| GO:0050998 | nitric-oxide synthase binding | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 16 | 
| GO:0030101 | natural killer cell activation | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 16 | 
| GO:0051603 | proteolysis involved in cellular protein catabolic process | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 2 | 16 | 
| GO:0005829 | cytosol | 1.05e-02 | 1.00e+00 | 1.683 | 5 | 132 | 2496 | 
| GO:0097194 | execution phase of apoptosis | 1.18e-02 | 1.00e+00 | 6.398 | 1 | 1 | 19 | 
| GO:0030276 | clathrin binding | 1.24e-02 | 1.00e+00 | 6.324 | 1 | 2 | 20 | 
| GO:0045862 | positive regulation of proteolysis | 1.30e-02 | 1.00e+00 | 6.254 | 1 | 1 | 21 | 
| GO:0030863 | cortical cytoskeleton | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 1 | 22 | 
| GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 4 | 22 | 
| GO:0043234 | protein complex | 1.37e-02 | 1.00e+00 | 3.442 | 2 | 18 | 295 | 
| GO:0043044 | ATP-dependent chromatin remodeling | 1.43e-02 | 1.00e+00 | 6.123 | 1 | 4 | 23 | 
| GO:0008135 | translation factor activity, nucleic acid binding | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 7 | 24 | 
| GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway | 1.55e-02 | 1.00e+00 | 6.002 | 1 | 3 | 25 | 
| GO:0042113 | B cell activation | 1.55e-02 | 1.00e+00 | 6.002 | 1 | 2 | 25 | 
| GO:0019901 | protein kinase binding | 1.57e-02 | 1.00e+00 | 3.338 | 2 | 21 | 317 | 
| GO:1900740 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 4 | 26 | 
| GO:0009409 | response to cold | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 2 | 26 | 
| GO:0043022 | ribosome binding | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 3 | 27 | 
| GO:0050661 | NADP binding | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 2 | 27 | 
| GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 2 | 27 | 
| GO:0034612 | response to tumor necrosis factor | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 2 | 27 | 
| GO:0031492 | nucleosomal DNA binding | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 4 | 27 | 
| GO:0006099 | tricarboxylic acid cycle | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 4 | 28 | 
| GO:0030669 | clathrin-coated endocytic vesicle membrane | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 4 | 28 | 
| GO:0019894 | kinesin binding | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 1 | 28 | 
| GO:0042254 | ribosome biogenesis | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 1 | 30 | 
| GO:0033572 | transferrin transport | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 5 | 30 | 
| GO:0005164 | tumor necrosis factor receptor binding | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 2 | 30 | 
| GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 1 | 30 | 
| GO:0031623 | receptor internalization | 1.92e-02 | 1.00e+00 | 5.692 | 1 | 2 | 31 | 
| GO:0046677 | response to antibiotic | 1.92e-02 | 1.00e+00 | 5.692 | 1 | 2 | 31 | 
| GO:0005925 | focal adhesion | 2.05e-02 | 1.00e+00 | 3.130 | 2 | 19 | 366 | 
| GO:0032588 | trans-Golgi network membrane | 2.10e-02 | 1.00e+00 | 5.559 | 1 | 2 | 34 | 
| GO:0001895 | retina homeostasis | 2.10e-02 | 1.00e+00 | 5.559 | 1 | 1 | 34 | 
| GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors | 2.10e-02 | 1.00e+00 | 5.559 | 1 | 2 | 34 | 
| GO:0097110 | scaffold protein binding | 2.10e-02 | 1.00e+00 | 5.559 | 1 | 3 | 34 | 
| GO:0051539 | 4 iron, 4 sulfur cluster binding | 2.16e-02 | 1.00e+00 | 5.517 | 1 | 3 | 35 | 
| GO:0034332 | adherens junction organization | 2.22e-02 | 1.00e+00 | 5.476 | 1 | 1 | 36 | 
| GO:0008234 | cysteine-type peptidase activity | 2.29e-02 | 1.00e+00 | 5.437 | 1 | 3 | 37 | 
| GO:0051084 | 'de novo' posttranslational protein folding | 2.29e-02 | 1.00e+00 | 5.437 | 1 | 4 | 37 | 
| GO:0097191 | extrinsic apoptotic signaling pathway | 2.35e-02 | 1.00e+00 | 5.398 | 1 | 3 | 38 | 
| GO:0071407 | cellular response to organic cyclic compound | 2.35e-02 | 1.00e+00 | 5.398 | 1 | 2 | 38 | 
| GO:0070527 | platelet aggregation | 2.35e-02 | 1.00e+00 | 5.398 | 1 | 2 | 38 | 
| GO:0042110 | T cell activation | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 3 | 42 | 
| GO:0035872 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway | 2.65e-02 | 1.00e+00 | 5.220 | 1 | 4 | 43 | 
| GO:0006892 | post-Golgi vesicle-mediated transport | 2.65e-02 | 1.00e+00 | 5.220 | 1 | 3 | 43 | 
| GO:0021762 | substantia nigra development | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 2 | 44 | 
| GO:0044297 | cell body | 2.83e-02 | 1.00e+00 | 5.123 | 1 | 2 | 46 | 
| GO:0006921 | cellular component disassembly involved in execution phase of apoptosis | 2.90e-02 | 1.00e+00 | 5.092 | 1 | 5 | 47 | 
| GO:0006091 | generation of precursor metabolites and energy | 3.08e-02 | 1.00e+00 | 5.002 | 1 | 3 | 50 | 
| GO:0004197 | cysteine-type endopeptidase activity | 3.08e-02 | 1.00e+00 | 5.002 | 1 | 3 | 50 | 
| GO:0003725 | double-stranded RNA binding | 3.20e-02 | 1.00e+00 | 4.946 | 1 | 5 | 52 | 
| GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 5 | 53 | 
| GO:0008233 | peptidase activity | 3.32e-02 | 1.00e+00 | 4.891 | 1 | 2 | 54 | 
| GO:0045216 | cell-cell junction organization | 3.32e-02 | 1.00e+00 | 4.891 | 1 | 2 | 54 | 
| GO:0044267 | cellular protein metabolic process | 3.33e-02 | 1.00e+00 | 2.757 | 2 | 29 | 474 | 
| GO:0097193 | intrinsic apoptotic signaling pathway | 3.38e-02 | 1.00e+00 | 4.865 | 1 | 6 | 55 | 
| GO:0051291 | protein heterooligomerization | 3.44e-02 | 1.00e+00 | 4.839 | 1 | 2 | 56 | 
| GO:0035091 | phosphatidylinositol binding | 3.74e-02 | 1.00e+00 | 4.715 | 1 | 3 | 61 | 
| GO:0071260 | cellular response to mechanical stimulus | 3.98e-02 | 1.00e+00 | 4.624 | 1 | 5 | 65 | 
| GO:0034329 | cell junction assembly | 4.17e-02 | 1.00e+00 | 4.559 | 1 | 1 | 68 | 
| GO:0032355 | response to estradiol | 4.35e-02 | 1.00e+00 | 4.496 | 1 | 5 | 71 | 
| GO:0006915 | apoptotic process | 4.45e-02 | 1.00e+00 | 2.530 | 2 | 33 | 555 | 
| GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 4.53e-02 | 1.00e+00 | 4.437 | 1 | 6 | 74 | 
| GO:0008584 | male gonad development | 4.59e-02 | 1.00e+00 | 4.417 | 1 | 3 | 75 | 
| GO:0035666 | TRIF-dependent toll-like receptor signaling pathway | 4.64e-02 | 1.00e+00 | 4.398 | 1 | 3 | 76 | 
| GO:0002756 | MyD88-independent toll-like receptor signaling pathway | 4.76e-02 | 1.00e+00 | 4.361 | 1 | 3 | 78 | 
| GO:0070062 | extracellular vesicular exosome | 4.77e-02 | 1.00e+00 | 1.417 | 4 | 104 | 2400 | 
| GO:0034138 | toll-like receptor 3 signaling pathway | 4.82e-02 | 1.00e+00 | 4.342 | 1 | 3 | 79 | 
| GO:0045087 | innate immune response | 5.06e-02 | 1.00e+00 | 2.427 | 2 | 24 | 596 | 
| GO:0006898 | receptor-mediated endocytosis | 5.12e-02 | 1.00e+00 | 4.254 | 1 | 3 | 84 | 
| GO:0045471 | response to ethanol | 5.24e-02 | 1.00e+00 | 4.220 | 1 | 3 | 86 | 
| GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 5.48e-02 | 1.00e+00 | 4.154 | 1 | 7 | 90 | 
| GO:0042470 | melanosome | 5.54e-02 | 1.00e+00 | 4.138 | 1 | 9 | 91 | 
| GO:0006928 | cellular component movement | 5.54e-02 | 1.00e+00 | 4.138 | 1 | 7 | 91 | 
| GO:0001649 | osteoblast differentiation | 5.60e-02 | 1.00e+00 | 4.123 | 1 | 6 | 92 | 
| GO:0034142 | toll-like receptor 4 signaling pathway | 5.83e-02 | 1.00e+00 | 4.061 | 1 | 3 | 96 | 
| GO:0014069 | postsynaptic density | 6.37e-02 | 1.00e+00 | 3.932 | 1 | 3 | 105 | 
| GO:0005506 | iron ion binding | 6.37e-02 | 1.00e+00 | 3.932 | 1 | 4 | 105 | 
| GO:0005741 | mitochondrial outer membrane | 6.37e-02 | 1.00e+00 | 3.932 | 1 | 7 | 105 | 
| GO:0006897 | endocytosis | 6.43e-02 | 1.00e+00 | 3.918 | 1 | 8 | 106 | 
| GO:0002224 | toll-like receptor signaling pathway | 6.60e-02 | 1.00e+00 | 3.878 | 1 | 3 | 109 | 
| GO:0005815 | microtubule organizing center | 6.60e-02 | 1.00e+00 | 3.878 | 1 | 5 | 109 | 
| GO:0072562 | blood microparticle | 6.72e-02 | 1.00e+00 | 3.852 | 1 | 3 | 111 | 
| GO:0030529 | ribonucleoprotein complex | 6.78e-02 | 1.00e+00 | 3.839 | 1 | 8 | 112 | 
| GO:0005819 | spindle | 6.78e-02 | 1.00e+00 | 3.839 | 1 | 7 | 112 | 
| GO:0044237 | cellular metabolic process | 7.07e-02 | 1.00e+00 | 3.776 | 1 | 5 | 117 | 
| GO:0006325 | chromatin organization | 7.13e-02 | 1.00e+00 | 3.764 | 1 | 5 | 118 | 
| GO:0005730 | nucleolus | 7.30e-02 | 1.00e+00 | 1.551 | 3 | 69 | 1641 | 
| GO:0032496 | response to lipopolysaccharide | 7.30e-02 | 1.00e+00 | 3.727 | 1 | 4 | 121 | 
| GO:0016020 | membrane | 7.75e-02 | 1.00e+00 | 1.516 | 3 | 90 | 1681 | 
| GO:0000790 | nuclear chromatin | 7.77e-02 | 1.00e+00 | 3.635 | 1 | 9 | 129 | 
| GO:0031982 | vesicle | 7.89e-02 | 1.00e+00 | 3.613 | 1 | 9 | 131 | 
| GO:0007507 | heart development | 8.35e-02 | 1.00e+00 | 3.527 | 1 | 7 | 139 | 
| GO:0006457 | protein folding | 8.58e-02 | 1.00e+00 | 3.486 | 1 | 7 | 143 | 
| GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 8.69e-02 | 1.00e+00 | 3.466 | 1 | 4 | 145 | 
| GO:0005198 | structural molecule activity | 8.98e-02 | 1.00e+00 | 3.417 | 1 | 5 | 150 | 
| GO:0042981 | regulation of apoptotic process | 8.98e-02 | 1.00e+00 | 3.417 | 1 | 24 | 150 | 
| GO:0045121 | membrane raft | 9.33e-02 | 1.00e+00 | 3.361 | 1 | 8 | 156 | 
| GO:0043005 | neuron projection | 9.38e-02 | 1.00e+00 | 3.352 | 1 | 6 | 157 | 
| GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 9.84e-02 | 1.00e+00 | 3.280 | 1 | 7 | 165 | 
| GO:0030424 | axon | 9.90e-02 | 1.00e+00 | 3.271 | 1 | 4 | 166 | 
| GO:0006886 | intracellular protein transport | 1.02e-01 | 1.00e+00 | 3.228 | 1 | 5 | 171 | 
| GO:0031625 | ubiquitin protein ligase binding | 1.06e-01 | 1.00e+00 | 3.170 | 1 | 14 | 178 | 
| GO:0032403 | protein complex binding | 1.09e-01 | 1.00e+00 | 3.130 | 1 | 10 | 183 | 
| GO:0001525 | angiogenesis | 1.13e-01 | 1.00e+00 | 3.069 | 1 | 4 | 191 | 
| GO:0001701 | in utero embryonic development | 1.19e-01 | 1.00e+00 | 2.995 | 1 | 8 | 201 | 
| GO:0005515 | protein binding | 1.20e-01 | 1.00e+00 | 0.675 | 6 | 184 | 6024 | 
| GO:0005634 | nucleus | 1.20e-01 | 1.00e+00 | 0.814 | 5 | 136 | 4559 | 
| GO:0005739 | mitochondrion | 1.25e-01 | 1.00e+00 | 1.683 | 2 | 28 | 998 | 
| GO:0007067 | mitotic nuclear division | 1.33e-01 | 1.00e+00 | 2.820 | 1 | 14 | 227 | 
| GO:0005759 | mitochondrial matrix | 1.34e-01 | 1.00e+00 | 2.813 | 1 | 14 | 228 | 
| GO:0006412 | translation | 1.35e-01 | 1.00e+00 | 2.801 | 1 | 20 | 230 | 
| GO:0044822 | poly(A) RNA binding | 1.37e-01 | 1.00e+00 | 1.602 | 2 | 49 | 1056 | 
| GO:0005975 | carbohydrate metabolic process | 1.47e-01 | 1.00e+00 | 2.663 | 1 | 9 | 253 | 
| GO:0003779 | actin binding | 1.54e-01 | 1.00e+00 | 2.591 | 1 | 12 | 266 | 
| GO:0044281 | small molecule metabolic process | 1.71e-01 | 1.00e+00 | 1.404 | 2 | 58 | 1211 | 
| GO:0030154 | cell differentiation | 1.73e-01 | 1.00e+00 | 2.413 | 1 | 5 | 301 | 
| GO:0043231 | intracellular membrane-bounded organelle | 1.82e-01 | 1.00e+00 | 2.333 | 1 | 9 | 318 | 
| GO:0007411 | axon guidance | 1.82e-01 | 1.00e+00 | 2.329 | 1 | 13 | 319 | 
| GO:0005737 | cytoplasm | 1.87e-01 | 1.00e+00 | 0.767 | 4 | 110 | 3767 | 
| GO:0003723 | RNA binding | 1.94e-01 | 1.00e+00 | 2.228 | 1 | 20 | 342 | 
| GO:0006508 | proteolysis | 2.13e-01 | 1.00e+00 | 2.084 | 1 | 9 | 378 | 
| GO:0046982 | protein heterodimerization activity | 2.14e-01 | 1.00e+00 | 2.076 | 1 | 13 | 380 | 
| GO:0055114 | oxidation-reduction process | 2.34e-01 | 1.00e+00 | 1.932 | 1 | 12 | 420 | 
| GO:0007596 | blood coagulation | 2.51e-01 | 1.00e+00 | 1.816 | 1 | 18 | 455 | 
| GO:0016032 | viral process | 2.88e-01 | 1.00e+00 | 1.585 | 1 | 55 | 534 | 
| GO:0005794 | Golgi apparatus | 3.22e-01 | 1.00e+00 | 1.393 | 1 | 15 | 610 | 
| GO:0010467 | gene expression | 3.48e-01 | 1.00e+00 | 1.260 | 1 | 59 | 669 | 
| GO:0005615 | extracellular space | 4.61e-01 | 1.00e+00 | 0.744 | 1 | 17 | 957 | 
| GO:0006355 | regulation of transcription, DNA-templated | 4.75e-01 | 1.00e+00 | 0.685 | 1 | 18 | 997 | 
| GO:0005654 | nucleoplasm | 5.04e-01 | 1.00e+00 | 0.567 | 1 | 76 | 1082 | 
| GO:0005524 | ATP binding | 5.72e-01 | 1.00e+00 | 0.304 | 1 | 60 | 1298 | 
| GO:0046872 | metal ion binding | 5.75e-01 | 1.00e+00 | 0.294 | 1 | 25 | 1307 | 
| GO:0006351 | transcription, DNA-templated | 6.14e-01 | 1.00e+00 | 0.148 | 1 | 31 | 1446 | 
| GO:0005886 | plasma membrane | 8.31e-01 | 1.00e+00 | -0.688 | 1 | 45 | 2582 |